Remeditex Ventures Llc - Net Worth and Insider Trading

Remeditex Ventures Llc Net Worth

The estimated net worth of Remeditex Ventures Llc is at least $208 Million dollars as of 2024-05-17. Remeditex Ventures Llc is the 10% Owner of Soliton Inc and owns about 9,214,277 shares of Soliton Inc (SOLY) stock worth over $208 Million. Remeditex Ventures Llc is also the 10% Owner of VYNE Therapeutics Inc and owns about 38,356 shares of VYNE Therapeutics Inc (VYNE) stock worth over $107,780. Details can be seen in Remeditex Ventures Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Remeditex Ventures Llc has not made any transactions after 2020-06-30 and currently still holds the listed stock(s).

Transaction Summary of Remeditex Ventures Llc

To

Remeditex Ventures Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Remeditex Ventures Llc owns 5 companies in total, including Soliton Inc (SOLY) , VYNE Therapeutics Inc (VYNE) , and Viridian Therapeutics Inc (VRDN) among others .

Click here to see the complete history of Remeditex Ventures Llc’s form 4 insider trades.

Insider Ownership Summary of Remeditex Ventures Llc

Ticker Comapny Transaction Date Type of Owner
SOLY Soliton Inc 2020-06-30 10 percent owner
VYNE VYNE Therapeutics Inc 2018-01-25 10 percent owner
VRDN Viridian Therapeutics Inc 2017-02-13 10 percent owner
2016-12-29 10 percent owner
2014-12-17 10 percent owner

Remeditex Ventures Llc Latest Holdings Summary

Remeditex Ventures Llc currently owns a total of 2 stocks. Among these stocks, Remeditex Ventures Llc owns 9,214,277 shares of Soliton Inc (SOLY) as of June 30, 2020, with a value of $208 Million and a weighting of 99.95%. Remeditex Ventures Llc also owns 38,356 shares of VYNE Therapeutics Inc (VYNE) as of January 25, 2018, with a value of $107,780 and a weighting of 0.05%.

Latest Holdings of Remeditex Ventures Llc

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SOLY Soliton Inc 2020-06-30 9,214,277 22.58 208,058,375
VYNE VYNE Therapeutics Inc 2018-01-25 38,356 2.81 107,780

Holding Weightings of Remeditex Ventures Llc


Remeditex Ventures Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, Remeditex Ventures Llc has made a total of 1 transactions in Soliton Inc (SOLY) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Soliton Inc is the acquisition of 120,481 shares on June 30, 2020, which cost Remeditex Ventures Llc around $999,992.

According to the SEC Form 4 filings, Remeditex Ventures Llc has made a total of 0 transactions in VYNE Therapeutics Inc (VYNE) over the past 5 years. The most-recent trade in VYNE Therapeutics Inc is the acquisition of 1,389 shares on January 25, 2018, which cost Remeditex Ventures Llc around $2 Million.

Insider Trading History of Remeditex Ventures Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Remeditex Ventures Llc Trading Performance

GuruFocus tracks the stock performance after each of Remeditex Ventures Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Remeditex Ventures Llc is -37.13%. GuruFocus also compares Remeditex Ventures Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Remeditex Ventures Llc within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Remeditex Ventures Llc's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Remeditex Ventures Llc

Average Return

Average return per transaction

Outperforming Transactions

1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 3.55
Relative Return to S&P 500(%) 2.81

Remeditex Ventures Llc Ownership Network

Ownership Network List of Remeditex Ventures Llc

No Data

Ownership Network Relation of Remeditex Ventures Llc


Remeditex Ventures Llc Owned Company Details

What does Soliton Inc do?

Who are the key executives at Soliton Inc?

Remeditex Ventures Llc is the 10 percent owner of Soliton Inc. Other key executives at Soliton Inc include Chief Operating Officer Joe D Tanner , Chief Financial Officer Lori Bisson , and director & CEO & President Christopher Capelli .

Soliton Inc (SOLY) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Soliton Inc (SOLY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Soliton Inc (SOLY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Soliton Inc (SOLY)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Soliton Inc Insider Transactions

No Available Data

Remeditex Ventures Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Remeditex Ventures Llc. You might contact Remeditex Ventures Llc via mailing address: 2101 Cedar Springs Road, Suite 601, Dallas Tx 75201.

Discussions on Remeditex Ventures Llc

No discussions yet.